In this episode of the Interventional Glaucoma podcast, host Dr. Cathy McCabe is joined by Dr. Mark Gallardo and Mr. Dan Lindfield to explore Elios, a minimally invasive and precise solution for patients with cataracts and glaucoma. The conversation delves into patient selection criteria, effective communication strategies, and the need for a shift towards holistic patient-centered care.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering,...

If the basic concept that impairment in aqueous humor outflow results in elevation of the IOP is a central tenet of glaucoma pathology and treatment; what three facts should all ophthalmologists know about aqueous humor dynamics?  Dr. Ike Ahmed and Professor Gus Gazzard sit down with Professor Carl Sheridan to answer this question. They highlight the clinical implications of understanding these dynamics while emphasizing the importance of early intervention and tissue preservation.

Dr. Ike Ahmed and Professor Gus Gazzard are joined by Professor Carl Sheridan to discuss the complexities of the trabecular meshwork and its significance in glaucoma management. They deconstruct some common myths and misconceptions surrounding the structure, and explore the importance of early intervention and precision treatments in obtaining maximum preservation.

Professor Gus Gazzard is joined by Ahmad Elsahn to delve into the use of excimer laser technology and its impact in shifting mindsets towards more interventional strategies for glaucoma patients. They provide insights into the distinct characteristics of the excimer laser, and discuss the safety and efficacy of the treatment.

Dr. Ike Ahmed and Professor Gus Gazzard kick off the Interventional Glaucoma podcast series with an unscripted discussion about the evolving mindset of interventional glaucoma.  They explore the motivations behind this shift, including the need to address the limitations of current treatments, and highlight cataract surgery as an opportune entry point to intervene with simultaneous glaucoma treatment.